NBIX
Neurocrine Biosciences Inc
141.30$
-1.5%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 34.9% | 42.1% | -66.9% | -61.3% | -127.8% | -53.0% | -439.8% | 26.7% | -117.4% | -24.9% | -253.2% | -4,847.5% | -1,865.8% | -1,798.0% | 149.1% | -0.9% | -66.4% | -1,014.3% | – | -192.2% | -707.9% | -58.4% | 22.5% | 18.7% | 21.8% | 22.6% | 22.8% | 20.7% | 25.3% | 27.4% | |
| 5.2% | 5.0% | 10.6% | 12.5% | 15.1% | 6.4% | 17.2% | 2.7% | 8.3% | 8.1% | 26.9% | 768.3% | 191.4% | 107.7% | 4.3% | 0.9% | 1.2% | 23.0% | – | 5.1% | 9.7% | 1.5% | 0.9% | 0.9% | 0.8% | 1.0% | 1.0% | 1.1% | 1.2% | 1.1% | |
| – | – | – | – | – | – | 6.6% | 1.2% | 0.6% | 0.4% | 36.6% | 815.6% | 201.1% | 187.6% | 9.4% | 3.8% | 10.3% | 233.6% | – | 143.6% | 189.8% | 26.3% | 12.9% | 9.6% | 9.6% | 11.8% | 11.6% | 10.3% | 8.3% | 7.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -0.3% | 4.5% | 125.0% | – | 126.8% | 166.9% | 25.0% | 12.7% | 9.6% | -18.0% | 12.6% | 17.9% | – | – | – | |
| -3.6% | 6.9% | -14.4% | 13.1% | 3.0% | 4.5% | 74.8% | 12.2% | -29.3% | 2.7% | -28.2% | 1,379.0% | -314.0% | -446.2% | -27.4% | -5.8% | -25.7% | 414.4% | – | 44.0% | 38.5% | -5.4% | -0.4% | -0.6% | -3.6% | 1.5% | -4.5% | 1.5% | -0.8% | -4.5% | |
| 8.3% | 24.5% | 23.1% | 12.5% | 16.7% | 9.2% | 29.4% | 36.3% | 62.4% | 5.8% | 7.9% | 51.0% | 33.3% | 1.2% | 0.9% | 1.0% | 1.8% | 18.7% | – | 9.8% | 27.4% | 4.3% | 5.5% | 1.9% | 1.0% | 2.1% | 1.1% | 1.5% | 1.6% | 1.2% | |
| – | -27.6% | 29.4% | -126.2% | -518.7% | -40.3% | -255.0% | -134.2% | 21.7% | 7.6% | 306.6% | 1,702.3% | 1,117.5% | 408.3% | -163.3% | -4.6% | -65.4% | 182.9% | – | -990.5% | 753.0% | -155.5% | -53.8% | -26.8% | 0.4% | -11.5% | -11.9% | -24.8% | -5.4% | -9.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0% | 0.0% | 0.0% | – | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.4% | 157.5% | 181.6% | – | 1,401.1% | 15.9% | 8.6% | 6.5% | 3.5% | 2.8% | 2.4% | 3.0% | 0.0% | -12.7% | -5.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2,543.3% | 3,351.9% | 311.1% | -41.4% | -23.7% | -17.9% | 0.0% | -18.7% | 0.0% | -13.1% | 0.0% | |
| 243.8% | 2.7% | 11.9% | 244.0% | 645.3% | 439.6% | 32.2% | 151.8% | 43.1% | 8.3% | 25.7% | 4,671.7% | -36.5% | 335.3% | 64.1% | 0.4% | 157.5% | 181.6% | – | 1,401.1% | 15.9% | 319.7% | 6.5% | 4.1% | -15.1% | 2.4% | -15.7% | 3.5% | -20.7% | -1.3% | |
| 25.5% | 17.2% | -25.6% | 57.1% | -1.3% | 346.3% | -662.6% | 44.2% | -52.6% | -8.9% | 79.1% | 1,526.4% | -784.8% | -1,054.5% | 49.9% | -5.1% | 25.7% | -649.7% | – | 218.4% | 61.1% | 105.8% | -24.8% | -4.0% | 7.2% | 13.6% | -4.9% | -0.6% | -0.8% | 16.8% | |
| 26.6% | 17.6% | -90.0% | -73.8% | -144.5% | -62.2% | -469.2% | -9.6% | -179.8% | -30.7% | -261.1% | -4,898.5% | -1,899.0% | -1,799.2% | 148.1% | -1.9% | -68.2% | -1,033.0% | – | -202.0% | -735.3% | -62.7% | 17.0% | 16.8% | 20.8% | 20.6% | 21.7% | 19.2% | 23.7% | 26.2% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.